| Impact of inducible nitric oxide synthase (iNOS) expression on triple negative breast cancer outcome and activation of EGFR and ERK signaling pathways P Garrido, A Shalaby, EM Walsh, N Keane, M Webber, MM Keane, ... Oncotarget 8 (46), 80568, 2017 | 80 | 2017 |
| Prognostic role of androgen receptor in triple negative breast cancer: a multi-institutional study S Bhattarai, S Klimov, K Mittal, U Krishnamurti, X Li, G Oprea-Ilies, ... Cancers 11 (7), 995, 2019 | 68 | 2019 |
| Perioperative chemotherapy in the treatment of osteosarcoma: a 26-year single institution review GM O’Kane, KA Cadoo, EM Walsh, R Emerson, P Dervan, C O’keane, ... Clinical sarcoma research 5, 1-8, 2015 | 58 | 2015 |
| A Review of Triple Negative Breast Cancer (TNBC) and the Impact of Inducible Nitric Oxide Synthase on TNBC Tumour Biology and Patient Outcomes E Walsh, M Keane, D Wink, G Callagy, S Glynn Critical Reviews in Oncogenesis, 0 | 56* | |
| Reproducibility and predictive value of scoring stromal tumour infiltrating lymphocytes in triple-negative breast cancer: a multi-institutional study M O’Loughlin, X Andreu, S Bianchi, E Chemielik, A Cordoba, G Cserni, ... Breast cancer research and treatment 171, 1-9, 2018 | 48 | 2018 |
| Economic impact of 21-gene recurrence score testing on early-stage breast cancer in Ireland L Smyth, G Watson, EM Walsh, CM Kelly, M Keane, MJ Kennedy, ... Breast cancer research and treatment 153, 573-582, 2015 | 35 | 2015 |
| Accelerating drug development in breast cancer: New frontiers for ER inhibition E Ferraro, EM Walsh, JJ Tao, S Chandarlapaty, K Jhaveri Cancer Treatment Reviews 109, 102432, 2022 | 30 | 2022 |
| Management of hormone receptor-positive, HER2-negative early breast cancer EM Walsh, KL Smith, V Stearns Seminars in oncology 47 (4), 187-200, 2020 | 29 | 2020 |
| Outcome for triple negative breast cancer in a retrospective cohort with an emphasis on response to platinum-based neoadjuvant therapy EM Walsh, A Shalaby, M O'Loughin, N Keane, MJ Webber, MJ Kerin, ... Breast Cancer Research and Treatment, 2018 | 27 | 2018 |
| Abstract GS4-08: Comprehensive genomic profiling of patients with breast cancer identifies germline-somatic interactions mediating therapy resistance A Safonov, C Bandlamudi, PT de Lara, E Ferraro, F Derakhshan, M Will, ... Cancer Research 82 (4_Supplement), GS4-08-GS4-08, 2022 | 22 | 2022 |
| Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: a feasibility study EM Walsh, A Gucalp, S Patil, M Edelweiss, DS Ross, P Razavi, S Modi, ... Breast cancer research and treatment 195 (3), 341-351, 2022 | 8 | 2022 |
| Effect of delays in initiation of adjuvant endocrine therapy on survival among women with breast cancer KT Lee, L Jacobs, EM Walsh, V Stearns, JB Segal Breast cancer research and treatment 184, 965-975, 2020 | 7 | 2020 |
| Is chemotherapy always required for cancer in pregnancy? An observational study E. M. Walsh, G. M. O’Kane, K. A. Cadoo, D. M. Graham, G. J. Korpanty, D. G ... Irish Journal of Medical Science, 2017 | 7 | 2017 |
| Olaparib use in patients with metastatic breast cancer harboring somatic BRCA1/2 mutations or mutations in non-BRCA1/2, DNA damage repair genes EM Walsh, N Mangini, J Fetting, D Armstrong, IS Chan, RM Connolly, ... Clinical breast cancer 22 (4), 319-325, 2022 | 6 | 2022 |
| Extended endocrine therapy for early-stage breast cancer: how do we decide? EM Walsh, R Nunes, MJ Wilkinson, CA Santa-Maria Current oncology reports 22, 1-10, 2020 | 6 | 2020 |
| Single agent anti PD-1 inhibitors in esophageal cancer—A first step in a new therapeutic direction EM Walsh, RJ Kelly Journal of Thoracic Disease 10 (3), 1308, 2018 | 6 | 2018 |
| Pregnancy-associated breast cancer: evaluating maternal and foetal outcomes. A national study L Prior, R O’Dwyer, AR Farooq, M Greally, C Ward, C O’Leary, R Aslam, ... Breast Cancer Research and Treatment 189 (1), 269-283, 2021 | 5 | 2021 |
| Breast cancer detection among Irish BRCA1 & BRCA2 mutation carriers: a population-based study EM Walsh, MP Farrell, C Nolan, F Gallagher, R Clarke, JA McCaffrey, ... Irish Journal of Medical Science (1971-) 185, 189-194, 2016 | 4 | 2016 |
| FOLFIRINOX in pancreatic cancer: Can results be reproduced outside the clinical trial setting? EMA Walsh, MY Teo, S Blaskova, PP Donnellan, MM Keane, GD Leonard Journal of Clinical Oncology 32 (15_suppl), e15236-e15236, 2014 | 4 | 2014 |
| Molecular tumor board guides successful treatment of a rare, locally aggressive, uterine mesenchymal neoplasm EM Walsh, D Xing, MH Lippitt, AN Fader, SL Wethington, CF Meyer, ... JCO Precision Oncology 5, 2021 | 2 | 2021 |
